White Paper: A Dual-Protective Strategy for Light-Sensitive ADCs - Stevanato Group

Antibody-Drug Conjugates (ADCs) can have their effectiveness compromised by exposure to light. Discover more on glass container applications with Low Delamination Propensity and amber light shielding. Download the White Paper.

Stevanato Group | Pharma & Biotech Integrated Solutions - Stevanato Group > White Paper: A Dual-Protective Strategy for Light-Sensitive ADCs - Stevanato Group